Delivery Order SPE2DB24D2012-SPE2DB25FBVBU

Award Date 1/10/25
Potential Completion Date 1/13/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 4,559,171,368 tablets of Pantoprazole Sodium Delayed-Release 40 mg, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,225.67 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 22, 2022, with a completion date of November 23, 2022. The contract is not designated under any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of 4,563,401,913 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets to the Defense Logistics Agency (DLA). The contract has a ceiling value of $5,038.98 and was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of January 23, 2024. This award is not designated with a set-aside requirement. AmerisourceBergen holds a significant...
This federal contract award, with ID SPE2DB20D1004|SPE2DB23FF0H6, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,111.76 firm fixed price delivery order is for the supply of 4,559,476,715 units of Pantoprazole Sodium Delayed-Release 40 mg tablets. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award is for the delivery of Pantoprazole Sodium Delayed-Release 40 mg Tablets in 1,000-count bottles. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under a Firm Fixed Price Delivery Order contract. The award has a ceiling value of $1,075.17 and a completion date of November 3, 2021. This contract is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4,566,436,564 units of Pantoprazole Sodium Delayed-Release 40 mg tablets to the Defense Logistics Agency (DLA). The $1,087.95 Firm Fixed Price delivery order contract has an ultimate completion date of November 15, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, as well as a separate $750,000...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,565,644,526 units of Pantoprazole Sodium Delayed-Release 40 mg tablets. The $1,415.98 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of September 3, 2024. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp, the prime contractor, is a for-profit organization...
This federal contract award, valued at $1,005.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,517,461 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets, with a completion date of November 22, 2024. The contract is a Delivery Order, with a Firm Fixed Price pricing type. It is not designated with any set-aside requirements, indicating open...
This federal contract award is for the delivery of 450 tablets of Pantoprazole Sodium Delayed-Release 40 mg, a prescription medication. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC enables efficient...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,561,368,146 units of Pantoprazole Sodium Delayed-Release 40 mg tablets. The contract has a ceiling value of $1,075.96 and an ultimate completion date of June 29, 2023. This contract is not designated as a set-aside and was awarded as a firm-fixed-price contract. AmerisourceBergen holds a larger Indefinite...
This federal contract award is for the delivery of Pantoprazole Sodium Delayed-Release (DR) 40 mg tablets in quantities of 1,000 per bottle. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,833.60 and a completion date of December 7, 2022. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and...
  • SPE2DB24D2012
    Indefinite Delivery Contract
  • SPE2DB24D2012-SPE2DB25FBVBU
    Delivery Order

This contract award is for the delivery of 4,566,894,411 units of Pantoprazole Sodium Delayed-Release Tablets, 40 mg, to the Defense Logistics Agency (DLA). The $1,233.77 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 10, 2025, with a period of performance through January 13, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.

Generated 4/13/25, 12:45 AM